Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome

Gérard Ailhaud

doi:10.1016/j.crvi.2005.12.012

Medical sciences / Sciences médicales

Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
[Sécrétions du tissu adipeux : de l'adipogénèse au syndrome métabolique]

Présenté par : Daniel Ricquier

Gérard Ailhaud ¹

¹ ISDBC, centre de biochimie, UMR 6543 CNRS, laboratoire « developpement du tissu adipeux », faculté des sciences, parc Valrose, 06108 Nice cedex 2, France

Comptes Rendus. Biologies, Maladies du tissu adipeux, Volume 329 (2006) no. 8, pp. 570-577.

Résumés

Anglais
Français

Adipose tissue contains various types of cells that include preadipocytes and adipocytes. Studies have emphasized that (i) preadipocytes secrete factors involved in their own differentiation and (ii) adipocytes acquire the ability to communicate systemically with other organs (brain, liver, skeletal muscle) and locally with other cells (preadipocytes, endothelial cells and monocytes/macrophages). Adipocytes secrete proteins exhibiting either beneficial (leptin, adiponectin) or deleterious effects (angiotensinogen). Associated to the effect of secretory products from macrophages (cytokines), a disturbance in the balance between these various secreted factors leads to the development of a metabolic syndrome.

Au cours de la dernière décennie, les études ont montré que les préadipocytes secrètent des facteurs participant à leur propre différenciation. Les adipocytes ainsi formés acquièrent la capacité de communiquer soit par la voie systémique avec d'autres organes (cerveau, foie, muscle squelettique) soit localement avec d'autres cellules (préadipocytes, cellules endothéliales, monocytes/macrophages). Ils sécrètent de nombreuses protéines excerçant des effets soit bénéfiques (leptine, adiponectine) soit délétères (angiotensinogène). Associés à l'effet de produits de sécretion des macrophages environnants (cytokines), un déséquilibre entre ces divers facteurs sécrétés conduit à l'établissement d'un syndrome métabolique.

Métadonnées

Reçu le : 2005-12-13
Accepté le : 2005-12-20
Publié le : 2006-05-03

PMID

DOI : 10.1016/j.crvi.2005.12.012

Keywords: Adipose tissue, Endocrine organ, Preadipocytes, Adipocytes, Secretory products, Metabolic syndrome
Mots-clés : Tissu adipeux, Organe endocrine, Préadipocytes, Adipocytes, Produits de sécrétion, Syndrome métabolique

Affiliations des auteurs :

Gérard Ailhaud ¹

¹ ISDBC, centre de biochimie, UMR 6543 CNRS, laboratoire « developpement du tissu adipeux », faculté des sciences, parc Valrose, 06108 Nice cedex 2, France

@article{CRBIOL_2006__329_8_570_0,
     author = {G\'erard Ailhaud},
     title = {Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome},
     journal = {Comptes Rendus. Biologies},
     pages = {570--577},
     publisher = {Elsevier},
     volume = {329},
     number = {8},
     year = {2006},
     doi = {10.1016/j.crvi.2005.12.012},
     language = {en},
}

TY  - JOUR
AU  - Gérard Ailhaud
TI  - Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
JO  - Comptes Rendus. Biologies
PY  - 2006
SP  - 570
EP  - 577
VL  - 329
IS  - 8
PB  - Elsevier
DO  - 10.1016/j.crvi.2005.12.012
LA  - en
ID  - CRBIOL_2006__329_8_570_0
ER  -

%0 Journal Article
%A Gérard Ailhaud
%T Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
%J Comptes Rendus. Biologies
%D 2006
%P 570-577
%V 329
%N 8
%I Elsevier
%R 10.1016/j.crvi.2005.12.012
%G en
%F CRBIOL_2006__329_8_570_0

Gérard Ailhaud. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. Comptes Rendus. Biologies, Maladies du tissu adipeux, Volume 329 (2006) no. 8, pp. 570-577. doi : 10.1016/j.crvi.2005.12.012. https://comptes-rendus.academie-sciences.fr/biologies/articles/10.1016/j.crvi.2005.12.012/

Version originale du texte intégral

Le texte intégral ci-dessous peut contenir quelques erreurs de conversion par rapport à la version officielle de l'article publié.

1 Introduction

Excess fat mass, which is characterized by an increase of fat cell size and number, is accompanied by the propensity of obese individuals to exhibit various features of the metabolic syndrome, i.e. insulin resistance leading to type 2 diabetes, hypertension and dyslipidemia. Moreover, based upon large scale epidemiological studies, a relationship is found between BMI and the incidence of cancer, e.g., breast cancer. Together, these observations imply that adipocytes and/or other cell types present within adipose tissue are able to cross-talk with other organs through secreted products. Although adipocytes have been recognized as secretory cells for a long time [1] and the number of secreted proteins is estimated at a few hundred [2], the cloning of the ob gene and the role of leptin [3,4] have definitely assessed adipose tissue as an endocrine organ. As we will see below, alterations in the production of leptin and other secreted proteins have substantial effects on body adiposity and components of the metabolic syndrome. Recently, the importance of macrophages in the adipose tissue of obese animals and individuals has been recognized and has increased our understanding of the initiation of a metabolic syndrome and the cross-talk within adipose tissue [5–9].

Another important aspect of adipose tissue biology is that adipocyte precursor cells are endowed with secretory properties whose products, associated with circulating hormones, participate in their own differentiation process, termed adipogenesis. Lastly, it is now recognized that the stromal-vascular compartment of adipose tissue contains various precursor cells and stem cells which give rise to different lineages in vitro and in vivo. This may ultimately be responsible for the self-renewal of adipocyte progenitor cells observed when sub-cutaneous adipose tissue expands continuously, as is the case in patients suffering from morbid obesity.

2 Secreted factors from preadipocytes and adipogenesis

The circulating hormones implicated in adipogenesis have been characterized and shown to be active in murine and human pre-adipocytes, e.g., glucocorticoids and insulin [10]. However, extracellular factors secreted from pre-adipocytes and triggering intracellular signalling pathways are also implicated in the early events of adipogenesis. In vitro studies mainly performed with murine pre-adipocyte clonal lines have shown that three redundant ligand/receptor systems are functional and concur to the up-regulation of CAAT/enhancer binding proteins (C/EBPs) β and δ whose gene invalidation in vivo impairs severely adipose tissue formation [11] (Fig. 1). The first system described involves prostacyclin which, after synthesis from arachidonic acid, is released and binds to a cell surface receptor IP-R. In the presence of arachidonic acid, cycloxygenase inhibitors (aspirin, indomethacin) as well as antibodies added externally and directed toward prostacyclin decrease by 40–70% adipogenesis [12–15]. Thus prostacyclin is able, after secretion, to act as a paracrine/autocrine effector in this process. Of note is carbacyclin, a stable analogue of prostacyclin, which promotes ex vivo and in vivo the formation of adipocytes within a few hours [16].

Fig. 1
Secreted factors from preadipocytes and adipocytes involved in adipogenesis and the metabolic syndrome. AGT, angiotensinogen; AngII, angiotensin II; CSF-1, colony stimulating factor-1; FIAF, fasting-induced adipose factor; FGF-10, fibroblast growth factor-10; IL, interleukin; LIF, leukaemia inhibitory factor; LPL, lipoprotein lipase; MCP-1, monocyte chemoattractant protein-1; N, nucleus; PAI-1, plasminogen activator inhibitor-1; PGI₂, prostacyclin; PTX3, pentraxin 3, TNF-α, tumour necrosis factor-α; TG, triglycerides. Intracellular signalling pathways are indicated by white arrows.

Prostacyclin, and its stable analogue carbacyclin, are able to induce a rise in cAMP levels and the activation of the protein kinase A (PKA) pathway. Most importantly, after differentiation, prostacyclin is no longer produced and IP-R appears non-functional [15]. The second ligand/receptor system involves leukaemia inhibitory factor (LIF) and LIF receptor which are also developmentaly regulated. Pre-adipocytes, but no longer adipocytes, secrete bioactive LIF, and an antagonist of LIF receptor inhibits by ∼60% adipogenesis. Early expression of C/EBPβ and C/EBPδ is rapidly stimulated following exposure to LIF through the activation of the ERK pathway [17].

The third ligand/receptor system involves secreted fibroblast growth factor-10 (FGF-10) which, after binding to its cognate cell surface receptor [18], up-regulates C/EBPβ expression. Thus it is clear that extensive redundancy is taking place to ensure adipogenesis, in accordance with the need of adipose tissue to ensure physiological functions. In vivo data are in good agreement with these in vitro observations. Prostacyclin receptor knockout mice appears as a key player during the gestation/suckling period in promoting the enhancing effect of linoleic acid (C18:2 $n - 6$ ), a precursor of arachidonic acid and thus of prostacyclin, on fat tissue development [19]. Not unexpectedly, a lack of LIF gene expression does not prevent this development as LIF-related cytokines, such as interleukin-6 (IL-6), cardiotropin-1 (CT-1) and ciliary neurotrophic factor (CNTF), can compensate in LIF-knockout mice by acting through the LIF receptor which recognizes these various ligands. Unfortunately, invalidation of the LIF receptor gene is lethal, precluding any study on adipose tissue development. Lastly, the development of this tissue is markedly reduced in mice invalidated for the FGF receptor gene [18]. The paucity of data, if any, on the factors secreted by human pre-adipocytes, prevents the drawing of any conclusion similar to rodent data. However, the importance of the linoleic acid/arachidonic acid/prostacyclin pathway in excessive adipose tissue development is suggested by the striking relationship observed during the last four decades between the dramatic increase in both the linoleic and arachidonic content of ingested fats and the increasing prevalence of overweight and obesity in infants, i.e. at a time where a positive energy balance is not yet an ongoing process [20,21].

3 Secreted factors from adipocytes

An amazing number of proteins and other factors secreted from adipocytes have been characterized over the last fifteen years. However, we will limit our discussion to the secreted factors which have been shown to play a role in the development of a metabolic syndrome and which participate in the cross-talk between cells within adipose tissue and which are implicated in adipose tissue expansion. Secretion of pro-inflammatory proteins will be briefly mentioned as they are discussed elsewhere in this issue.

3.1 Leptin

Leptin (16 kDa) is predominantly but not exclusively expressed in adipocytes, the subcutaneous adipose depot being the major source. Among adipokines secreted from fat cells, its key role is to provide a message from the periphery to the central nervous system (CNS). As such, it regulates energy balance – intake and expenditure – by inhibiting orexigenic pathways and stimulating anorexigenic pathways of the hypothalamus as described in innumerable publications and reviews [22–27]. In vitro and in vivo data support the idea that insulin indirectly stimulates leptin secretion via its increasing effects on glucose utilization in adipocytes. Interestingly, when high-fat meals are compared with high-carbohydrate/low-fat meals, leptin levels are reduced. This suggests a mechanism by which a high fat/high caloric diet favors overconsumption of calories and the subsequent weight gain.

Leptin levels are known to be associated with fat mass and are elevated in obese animals and individuals. Thus leptin resistance rather than the lack of circulating leptin occurs and explains the reasons why leptin therapy in obese patients has been unsuccessfull. It is now well accepted that the key role of leptin in the regulation of energy homeostasis is to function as a signal of negative energy balance and low energy stores. In the case of leptin deficiency in hyperphagic mice due to mutations in the ob gene, treatment with recombinant leptin restores metabolic, neuroendocrine, reproductive and immune functions. The presence of leptin receptor in various tissues – including the long form ObRb able to transduce the leptin-generated signal – suggests that leptin can also have direct peripheral effects in addition to central effects. This issue still remains controversial despite an impressive number of studies but it seems likely that a direct effect takes place in the immune system. However, under most experimental conditions which demonstrate peripheral effects, the levels of free circulating and bioactive leptin, i.e. not associated to the leptin transporter Ob-Re, are increased by several orders of magnitude. Consequently, it cannot be excluded that leptin could well trigger additional cytokine-related signalling pathways, e.g., IL-6, CNTF and LIF pathways. In addition to central and possibly peripheral effects, leptin has also the capacity to act locally where, similarly to vascular endothelial growth factor (VEGF), it exhibits potent angiogenic properties which contribute to adipose tissue growth [28,29].

3.2 Adiponectin

Adiponectin – also known as complement-related protein 30 (Acrp30), adipose most abundant gene transcript (apM1) and adipoQ – is a 30 kDa protein secreted from adipocytes and present in the circulation as dimer/trimer and higher-order complexes [24,30]. The adiponectin monomer contains a collagenous tail and a globular head domain. The subunits are linked through intermolecular disulfide bonds. Of note, a mutant form of adiponectin, lacking the critical cysteine residue (Cys39Ser) in the collagenous domain, exhibits higher bioactivity than the wild-type form [31]. Contrary to leptin, adiponectin levels are decreased in obese animals and patients. Adiponectin is a multifunctional protein which exerts pleiotropic insulin-sensitizing effects against cardiovascular disease. It lowers hepatic glucose production [32] and increases glucose uptake and fatty acid oxidation in skeletal muscle [33]. When ob/ob (leptin deficient) mice are overexpressing the Cys39Ser mutant form of adiponectin, the animals remain morbidly obese but exhibit normal glucose and lipid levels, emphasizing that adiponectin plays a major metabolic role at the periphery. Clearly, use of adiponectin for treatment of the metabolic syndrome is of great interest but relies on unanswered questions regarding the relationships between its structure(s) and function(s). For instance, it cannot be excluded that minor changes in total circulating levels routinely measured by commercial kits may correspond to more important changes in those of bioactive form(s) of adiponectin.

3.3 Resistin

Resistin is a 10 kDa protein secreted from rodent adipocytes which has been implicated in the development of insulin resistance [34]. In humans, contrary to rodents, macrophages appear as the main source [35]. Although normalization of resistin levels through antisense technology restores insulin sensitivity in mice, its functional role in humans remains elusive and requires further studies.

3.4 Lipoprotein lipase

Lipoprotein lipase (LPL) is a 55 kDa enzyme which can be considered as the prototype of secreted proteins from adipocytes [36]. Trying to detail its properties and the regulation of its activity is out of the scope of this review. LPL is a glycoprotein secreted by exocytosis from intracellular vesicles. Of note, insulin up-regulates LPL mainly at a post-translational level and calcium triggers its folding to active dimers [37]. Following transendothelial transport, it binds to proteolycans on the luminal side of the endothelium and becomes fully active in association with apolipoprotein C2 present on the surface of triglyceride-rich lipoprotein particles. LPL then gives rise to monoglycerides and fatty acids. Although not proven, LPL could act in concert with the acylating stimulating protein (ASP), thought to control fatty acid levels in the interstitial space, i.e. between endothelial cells and adipocytes (see below).

3.5 Acylation stimulating protein

The acylation stimulating protein (ASP) is a 8.9 kDa protein produced by adipose tissue after secretion from adipocytes of complement factor C, factor B and factor D (adipsin). Successive proteolytic events result in the formation of C3a which then gives rise to C3a desArg termed ASP. Although ASP is present in the circulation, its primary action appears local. In vitro, it stimulates triglyceride synthesis and glucose transport in adipocytes whereas in vivo C3 knockout mice, unable to produce ASP, exhibit a delayed post-prandial lipid clearance; these animals are hyperphagic but resistant to a high-fat diet, show increased energy expenditure and improved insulin sensitivity [38]. ASP may represent a metabolic link between the local environment of adipocytes and the regulation of a key adipocyte function, i.e. triglyceride storage. Recently, increases in ASP and factor C3 associated to a decrease in adiponectin levels in obese versus non-obese children have been observed, in the absence of lipid abnormalities at that age, suggesting a predisposition towards enhanced fat storage and decreased fat oxidation in the obese children [39]. Reducing ASP production from adipocytes is of potential interest against diet-induced weight gain, but will require further studies on its nutritional regulation. Interestingly, the orphan G protein-coupled receptor C5L2 has been recently characterized as a functional receptor for ASP [40]. However, C5L2 has a rather ubiquitous tissue distribution, with the highest levels in spleen. Thus finding C5L2 antagonists to modulate triglyceride storage in adipose tissue remains an interesting but difficult challenge.

3.6 Fasting-induced adipose factor

Recently a new gene has been identified, encoding the fasting-induced adipose factor (FIAF), also known as PPARγ angiopoietin-related protein (PGAR), angiopoietin-like protein 4 (ANGPLT4) or hepatic fibrinogen/angiopoietin-related protein (HFARP). FIAF encodes a secreted, angiopoietin/fibrinogen-like protein which is not exclusively produced in adipose tissue, but highly expressed under fasting conditions [41,42]. In mouse and human blood plasma, FIAF is present as the native 45 kDa protein and predominantly in a 32 kDa truncated form though a smaller 30 kDa form can also been observed [43]. Interestingly, the FIAF protein is proteolytically processed during adipocyte differentiation and its role in regulating lipid storage in adipose tissue has recently been proposed as FIAF is a potent lipoprotein-lipase (LPL) inhibitor in vitro and in vivo. Under fasting conditions, it is assumed that the high levels of circulating FIAF impairs LPL activity at a time where the circulating levels of LPL substrates, i.e. triglyceride-rich lipoprotein particles (chylomicrons and very low density lipoproteins), are very low. Conversely, its post-prandial decrease should allow LPL to hydrolyze triglyceride substrates in adipose tissue [44].

3.7 Visfatin and Vaspin

Visfatin (52 kDa) and Vaspin (45 kDa) are two newly identified adipokines which have been reported to be highly enriched in the visceral fat of humans and mice and whose plasma levels increase during weight gain [45]. Visfatin is identical to pre-B cell colony-enhancing factor (PBEF) known to be expressed in lymphocytes present in adipose tissue, whereas vaspin is a member of serine protease inhibitor family. Both proteins have a glucose-lowering effect. In rodents, visfatin mimics the effect of insulin but, considering its plasma concentration, its contribution in lowering glycemia should be small. In humans, a detailed study on 189 subjects shows no significant correlation between plasma levels and various parameters of insulin sensitivity. Moreover, the visfatin gene expression is similar between visceral and subcutaneous adipose tissue, whereas a significant correlation exists between this expression and BMI or percent body fat [46]. Taken together, these results indicate that rodent data can hardly be extrapolated to humans, raising concern about the physiological role of visfatin in patients. The role of vaspin as an insulin-sensitizer is even more difficult to envision in humans as its protective role in the development of type 2 diabetes has only been reported in mice [47].

3.8 Deleterious secreted factors acting through systemic and local effects

Owing to its sizeable mass, adipose tissue contributes also to the massive production of various proteins implicated in the metabolic syndrome and adipose tissue expansion. Adipocytes from white adipose tissue (WAT) represent a major extra-hepatic source of angiotensinogen (AGT). WAT contains all the components of the renin-angiotensin system which gives rise to angiotensin II (AngII) [48]. Hypertension is known as a frequent complication of obesity and although the mechanisms by which fat excess leads to hypertension have remained largely unknown, increased adipose AGT production could contribute to the elevation of blood pressure in obese patients. Insights into the relationships existing between adipose AGT, fat mass and blood pressure have been obtained through the generation of transgenic mice which either over-express adipose AGT or in which AGT expression is restricted to adipose tissue. From AGT knockout mice, re-expression of AGT confined to adipose tissue leads to the presence of AGT in the blood stream and the restoration of normal blood pressure. Importantly, from wild-type mice, overexpression of AGT in adipose tissue leads to enhanced plasma AGT levels and increased blood pressure [49].

Quite recently has been developed another transgenic model in which 11-β-hydroxysteroid-dehydrogenase-type 1 is overexpressed in adipose tissue. Transgenic mice develop abdominal obesity and the main features of the metabolic syndrome. In particular, mesenteric AGT mRNA is increased, due likely to an increase in the activity of the glucocorticoid receptor as a consequence of increased corticosterone levels in situ. Blood pressure measurements indicate that the animals are hypertensive. Together, these observations implicate adipose AGT in the regulation of blood pressure and are entirely consistent with human data [50].

Among the cluster of metabolic dysfunctions, hemostatic abnormalities associated with increased PAI-1 plasma levels are also a characteristic feature. Like vaspin, PAI-1 is a member of the SERPIN family. It inhibits fibrinolysis but also exhibits complex interaction with cellular matrix (ECM) components. Importantly, it is associated with fibrosis and thrombosis in animals and humans. PAI-1 is known to be overexpressed in adipose tissue of obese mice and individuals [51]. Surgical removal of fat in obese subjects is associated with a decrease in plasma PAI-1 levels. In addition to a systemic effect in atherothrombosis, recent reports are in favour of local effects of secreted PAI-1 in adipose tissue growth. PAI-1 deficiency, or inhibition of PAI-1 by neutralizing antibodies acting exogenously, promote adipocyte differentiation [52]. This observation is consistent with the fact that PAI-1 overexpressing mice gain weight slower than their wild-type counterparts [53]. It is conceivable that local alteration of PAI-1 levels affects remodelling of ECM and adipose tissue mass by altering the number and/or size of adipocytes. In agreement with this hypothesis, metalloproteinases 2 and 9, two key enzymes implicated in the ECM remodelling, are secreted from rodent and human adipocytes and their inhibition with specific inhibitors markedly decrease adipocyte differentiation [54,55]. The role of PAI-1 in adipose tissue development remains, however, controversial, as other reports show that PAI-1 overexpressing mice do not exhibit fat mass alteration but rather a higher insulin sensitivity [56]. Together with leptin acting as a potent angiogenic factor, adipocytes are secreting other proteins which promote, at least in rodents, fat mass growth through adipocyte hyperplasia. Autotaxin is a lysophospholipase D released from adipocytes able to hydrolyze lysophosphatidylcholine (produced from preadipocytes) to lysophosphatidic acid (LPA) [57]. LPA is recognized by the endothelial differentiation gene-2 receptor which is expressed in preadipocytes and triggers their proliferation and spreading [58] (Fig. 1). Thus, in adipose tissue, a cross-talk between adipocytes and preadipocytes could be envisionned through the generation of LPA acting as a paracrine factor. Lastly, angiotensin II arising from angiotensinogen secreted from adipocytes is able, after binding to the AT2 receptor present in pre-adipocytes, to trigger prostacyclin release and adipocyte differentiation [59]. Microdialysis of periepidydimal fat pad performed in rats with AngII demonstrate a similar enhancement of fat cell formation in vivo, i.e. adipocyte hyperplasia [16]. Moreover, in mice which are both overexpressing AGT in adipose tissue and deficient in AT₂ receptor, the results show that the up-regulation of fatty acid synthase does not take place, thus implicating the AT₂ receptor in enhanced lipogenesis in wild-type mice [60,61].

A major recent breaktrough is the observation that macrophage accumulation in adipose tissue takes place in obese animals and individuals in proportion to adipocyte size, and that the majority of macrophages originate from bone marrow [5–9]. Monocyte chemoattractant protein-1 (MCP-1) secreted from preadipocytes and adipocytes [62,63] as well as colony stimulating factor-1 (CSF-1) [64] secreted from adipocytes are postulated to participate in the recruitment of monocyte/macrophage implicated in chronic low-inflammatory state observed in obesity (Fig. 1). Macrophages within adipose tissue are able to secrete cytokines (tumour necrosis factor-α, IL-6,...) that are thought to participate in the emergence and/or the aggravation of insulin-resistance and the metabolic syndrome (see other articles in this issue). For instance, TNF-α strongly up-regulates in adipocytes the expression of pentraxin 3 [65] and haptoglobin [66] which may play a role in hemostasis and angiogenesis, respectively.

4 Conclusions

Among the genes encoding secreted proteins, only a few dozen of them have been characterized so far and the functions of a only small proportion of these proteins are presently well documented. As adipocytes play a key role in the regulatory cascades involved in the metabolic syndrome and in the cross-talk with major organs (brain, liver, muscles), it seems reasonable to assume that novel and major discoveries should be made in a near future.

Bibliographie

[1] G. Ailhaud; P. Grimaldi; R. Négrel Cellular and Molecular aspects of adipose tissue development, Annu. Rev. Nutr., Volume 12 (1992), pp. 207-233

[2] K. Maeda; K. Okubo; I. Shimomura; T. Funahashi; Y. Matsuzawa; K. Matsubara cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1, Biochem. Biophys. Res. Commun., Volume 221 (1996), pp. 286-289

[3] Y. Zhang; P. Proenca; M. Maffei; M. Barone; L. Leopold; J.M. Friedman Positional cloning of the mouse obese gene and its human homologue, Nature, Volume 372 (1994), pp. 425-432

[4] J.M. Friedman Role of leptin and its receptor in the control of body weight (W.F. Blum; W. Kiess; W. Rascher, eds.), Leptin – The Voice of Adipose Tissue, J.A. Barth Verlag, Edition J&J, 1997, pp. 3-22

[5] K.E. Wellen; G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue, J. Clin. Invest., Volume 112 (2003), pp. 1785-1788

[6] S.P. Weisberg; D. McCann; M. Desai; M. Rosenbaum; R.L. Leibel; A.W. Ferrante Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest., Volume 112 (2003), pp. 1796-1808

[7] H. Xu; G.T. Barnes; Q. Yang; G. Tan; D. Yang; C.J. Chou; J. Sole; A. Nichols; J.S. Ross; L.A. Tartaglia; H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J. Clin. Invest., Volume 112 (2003), pp. 1821-1830

[8] S. Cinti; G. Mitchell; G. Barbatelli; I. Murano; E. Ceresi; E. Faloia; S. Wang; M. Fortier; A.S. Greenberg; M.S. Obin Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J. Lipid Res., Volume 46 (2005), pp. 2347-2355

[9] R. Cancello; C. Henegar; N. Viguerie; S. Taleb; C. Poitou; C. Rouault; M. Coupaye; V. Pelloux; D. Hugol; J.-L. Bouillot; A. Bouloumie; G. Barbatelli; S. Cinti; P.A. Svensson; G.S. Barsh; J.D. Zucker; A. Basdevant; D. Langin; K. Clement Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss, Diabetes, Volume 54 (2005), pp. 2277-2286

[10] G. Ailhaud; H. Hauner Development of white adipose tissue (A.G. Bray; C. Bouchard, eds.), Handbook of Obesity: Etiology and Pathophysiology, Marcel Dekker, Inc., New York, USA, 2004, pp. 481-514

[11] T. Tanaka; N. Yoshida; T. Kishimoto; S. Akira Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene, EMBO J., Volume 16 (1997), pp. 7432-7443

[12] D. Gaillard; R. Negrel; M. Lagarde; G. Ailhaud Requirement and role of arachidonic acid in the differentiation of preadipose cells, Biochem. J., Volume 257 (1989), pp. 389-397

[13] R. Négrel; D. Gaillard; G. Ailhaud Prostacyclin as a potent effector of adipose cell differentiation, Biochem. J., Volume 257 (1989), pp. 399-405

[14] R.M. Cataliioto; D. Gaillard; J. Maclouf; G. Ailhaud; R. Négrel Autocrine control of adipose cell differentiation by prostacyclin and PGF2alpha, Biochim. Biophys. Acta, Volume 1091 (1991), pp. 364-369

[15] G. Vassaux; D. Gaillard; G. Ailhaud; R. Négrel Prostacyclin is a specific effector of adipose cell differentiation: its dual role as a cAMP- and Ca²⁺-elevating agent, J. Biol. Chem., Volume 267 (1992), pp. 11092-11097

[16] P. Saint-Marc; L.P. Kozak; G. Ailhaud; C. Darimont; R. Négrel Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation, Endocrinology, Volume 142 (2001), pp. 487-492

[17] J. Aubert; S. Dessolin; N. Belmonte; M. Li; F.R. McKenzie; L. Staccini; P. Villageois; B. Barhanin; A. Vernallis; A.G. Smith; G. Ailhaud; C. Dani Leukemia Inhibitory Factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade, J. Biol. Chem., Volume 274 (1999), pp. 24965-24972

[18] H. Sakaue; M. Konishi; W. Ogawa; T. Asaki; T. Mori; M. Yamasaki; M. Takata; H. Ueno; S. Kato; M. Kasuga; N. Itoh Requirement of fibroblast growth factor 10 in development of white adipose tissue, Genes Dev., Volume 16 (2002), pp. 908-912

[19] F. Massiéra; P. Saint-Marc; J. Seydoux; T. Murata; T. Kobayashi; S. Narumiya; P. Guesnet; E.Z. Amri; R. Négrel; G. Ailhaud Arachidonic acid and prostacyclin signalling promote adipose tissue development: a human health concern?, J. Lipid Res., Volume 44 (2003), pp. 271-279

[20] G. Ailhaud; P. Guesnet Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion, Obes. Rev., Volume 5 (2004), pp. 21-26

[21] G. Ailhaud, F. Massiéra, P. Weill, P. Legrand, J.M. Alessandri, P. Guesnet, Temporal changes in dietary fats: role of $n - 6$ polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity, Prog. Lipid Res. (2006), in press

[22] P.J. Havel Section IV: Lipid Modulators of Islet Function, Update on adipocyte hormones, Regulation of energy balance and carbohydrate/lipid metabolism, Diabetes, Volume 53 (2004), p. S143-S151

[23] M. Lafontan Fat cells: Afferent and efferent messages define new approaches to treat obesity, Annu. Rev. Pharmacol. Toxicol., Volume 45 (2005), pp. 119-146

[24] A.R. Naxrocki; P.E. Scherer The adipocyte as a drug discovery target, DDT, Volume 18 (2005), pp. 1219-1230

[25] F. Zhang; Y. Chen; M. Heiman; R. Dimarchi Leptin: structure and biology, Vitam. Horm., Volume 71 (2005), pp. 345-372

[26] J.R. Arch Central regulation of energy balance: inputs, outputs and leptin resistance, Proc. Nutr. Soc., Volume 64 (2005), pp. 39-46

[27] R.V. Considine Human leptin: and adipcyte hormone with weight-regulatory and endocrine functions, Semin. Vasc. Med., Volume 5 (2005), pp. 15-24

[28] A. Bouloumie; H.C. Drexler; M. Lafontan; R. Busse Leptin, the product of Ob gene, promotes angiogenesis, Circ. Res., Volume 83 (1998), pp. 1059-1066

[29] M.R. Sierra-Honignmann; A.K. Nath; C. Murakami; G. Garcia-Cardena; A. Ppapetropoulos; W.C. Sessa; L.A. Madge; J.S. Schechner; M.B. Schwabb; P.J. Polverini; J.R. Flores-Riveros Biological action of leptin as an agiogenic factor, Science, Volume 281 (1998), pp. 1683-1686

[30] Y. Matsuzawa Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease, Athersocler, Volume 6 (2005) no. Suppl., pp. 7-14

[31] U.B. Pajvani; X. Du; T.P. Combs; A.H. Berg; M.W. Rajala; T. Schulthess; J. Engel; M. Brownlee; P.E. Scherer Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity, J. Biol. Chem., Volume 278 (2003), pp. 9073-9085

[32] A.H. Berg; T.P. Combs; X. Du; M. Brownlee; P.E. Scherer The adipocyte-secreted-protein acrp30 enhances hepatic insulin action, Nat. Med., Volume 7 (2001), pp. 947-953

[33] T. Yamauchi; J. Kamon; Y. Minokoshi; Y. Ito; H. Waki; S. Uchida; S. Yamashita; M. Noda; S. Kita; K. Ueki; K. Eto; Y. Akanuma; P. Froguel; F. Foufelle; P. Ferré; D. Carling; S. Kimura; R. Nagai; B.B. Kahn; T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat. Med., Volume 8 (2002), pp. 1288-1295

[34] C.M. Steppan; M.A. Lazar The current biology of resistin, J. Intern. Med., Volume 255 (2004), pp. 439-447

[35] L. Patel; A.C. Buckels; I.J. Kinghorn; P.R. Murdoch; J.D. Holbrook; C. Plumpton; C.H. Macphee; S.A. Smith Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators, Biochem. Biophys. Res. Commun., Volume 300 (2003), pp. 472-476

[36] M. Merkel; R.H. Eckel; I.J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation, J. Lipid Res., Volume 43 (2002), pp. 1997-2006

[37] L. Zhang; A. Lookene; G. Wu; G. Olivecrona Calcium triggers folding of lipoprotein lipase to active dimers, J. Biol. Chem., Volume 280 (2005), pp. 42580-42591

[38] K. Cianflone; Z. Xia; L.Y. Chen Critical review of acylation-stimulating protein physiology in humans and rodents, Biochim. Biophys. Acta, Volume 1609 (2003), pp. 127-143

[39] K. Cianflone; H. Lu; J. Smith; W. Yu; H.W. Wang Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children, Clin. Endocrinol., Volume 62 (2005), pp. 567-572

[40] D. Kalan; R. MacLaren; W. Cui; R. Samanta; P.N. Monk; S.A. Laporte; K. Cianflone C5L2 is a functional receptor for acylation stimulating protein, J. Biol. Chem., Volume 25 (2005), pp. 23936-23944

[41] J.C. Yoon; T.W. Chickering; E.D. Rosen; B. Dussault; Y. Qin; A. Soukas; J.M. Friedman; W.E. Holmes; B.M. Spiegelman Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation, Mol. Cell. Biol., Volume 20 (2000), pp. 5343-5349

[42] S. Kersten; S. Mandard; N.S. Tan; P. Escher; D. Metzger; P. Chambon; F.J. Gonzalez; B. Desvergne; W. Wahli Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene, J. Biol. Chem., Volume 275 (2000), pp. 28488-28493

[43] S. Mandard; F. Zandbergen; N.S. Tan; P. Escher; D. Patsouris; W. Koenig; R. Kleemann; A. Bakker; F. Veenman; W. Wahli; M. Müller; S. Kersten The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenobibrate treatment, J. Biol. Chem., Volume 279 (2004), pp. 34411-34420

[44] F. Bäckhed; H. Ding; T. Wang; L.V. Hooper; G.Y. Koh; A. Nagy; C.F. Semenkovich; J.I. Gordon The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl Acad. Sci. USA, Volume 101 (2004), pp. 15718-15723

[45] A. Fukuhara; M. Matsuda; M. Nishizawa; K. Segawa; M. Tanaka; K. Kishimoto; Y. Matsuki; M. Murakami; T. Ichisaka; H. Murakami; E. Watanabe; T. Takagi; M. Aiyoshi; T. Ohtsubo; S. Kihara; S. Yamashita; M. Makishima; T. Funahashi; S. Yamanaka; R. Hiramatsu; Y. Matsuzawa; I. Shimomura Visfatin: A protein secreted by visceral fat that mimics the effects of insulin, Science, Volume 307 (2005), pp. 426-430

[46] J. Berndt; N. Kloting; S. Kralisch; P. Kovacs; M. Fasshauer; M.R. Schon; M. Stumvoll; M. Bluher Plasma visfatin concentrations and fat depot-specific mRNA expression in humans, Diabetes, Volume 54 (2005), pp. 2911-2916

[47] K. Hida; J. Wada; J. Eguchi; H. Zhang; M. Baba; A. Seida; I. Hashimoto; T. Okada; A. Yasuhara; A. Nakatsuka; K. Shikata; S. Hourai; J. Futami; E. Watanabe; Y. Matsuki; R. Hiramatsu; S. Akagi; H. Makino; Y.S. Kanwar Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity, Proc. Natl Acad. Sci. USA, Volume 102 (2005), pp. 10610-10615

[48] G. Ailhaud; M. Teboul; F. Massiéra Angiotensin, adipocyte differentiation and fat mass enlargement, Curr. Opin. Clin. Nutr. Metab. Care, Volume 5 (2002), pp. 385-389

[49] F. Massiéra; M. Bloch-Faure; D. Ceiler; K. Murakami; A. Fukamizu; J.M. Gasc; A. Quignard-Boulangé; R. Négrel; G. Ailhaud; J. Seydoux; P. Meneton; M. Teboul Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation, FASEB J. ( October 15, 2001 ) | DOI

[50] H. Masuzaki; H. Yamamoto; C.J. Kenyon; J.K. Elmquist; N.M. Morton; J.P. Parterson; H. Shinyama; M.G. Sharp; S. Fleming; J.J. Mullins; J.R. Seckl; J.S. Flier Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice, J. Clin. Invest., Volume 112 (2003), pp. 83-90

[51] M.C. Alessi; H.R. Lijnen; D. Bastelica; I. Juhan-Vague Adipose tissue and atherothrombosis, Pathophysiol. Haemost. Thromb., Volume 33 ( 2003/2004 ), pp. 290-297

[52] X. Liang; T. Kanjanabuch; S. Mao; C.M. Hao; T.W. Tang; P.J. Declerck; A.H. Hasty; D.H. Wasserman; A.B. Fogo; L.J. Ma Plasminogen activator inhibitor-I modulates adipocyte differentiation, Am. J. Physiol. Endocrinol. Metab., Volume 290 (2006), p. E103-E113

[53] H.R. Lijnen; E. Maquoi; P. Morange; G. Voros; B. Van Hoef; F. Kopp; D. Collen; I. Juhan-Vague; M.C. Alessi Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1, Atherioscler. Throm. Vasc. Biol., Volume 23 (2003), pp. 78-84

[54] A. Bouloumié; C. Sengenès; G. Portolan; J. Galitzky; M. Lafontan Adipocyte produces matrix metalloproteinases 2 and 9. Involvement in adipose differentiation, Diabetes, Volume 50 (2001), pp. 2080-2086

[55] D. Demeulemeester; D. Collen; H.R. Lijnen Effect of matrix metalloproteinase inhibition on adipose tissue development, Biochem. Biophys. Res. Commun., Volume 329 (2005), pp. 105-110

[56] H.R. Lijnen; M.C. Alessi; B. Van Hoef; D. Collen; I. Juhan-Vague On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice, J. Thromb. Haemost., Volume 3 (2005), pp. 1174-1179

[57] G. Ferry; E. Tellier; A. Try; S. Grès; I. Naime; M.F. Simon; M. Rodriguez; J. Boucher; I. Tack; S. Gesta; P. Chomarat; M. Dieu; M. Raes; J.P. Galizzi; P. Valet; J.A. Boutin; J.S. Saulnier-Blache Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation, J. Biol. Chem., Volume 278 (2003), pp. 18162-18169

[58] C. Pagès; D. Daviaud; S. An; S. Krief; M. Lafontan; P. Valet; J.S. Saulnier-Blache Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid-dependent control of 3T3F442A preadipocyte proliferation and spreading, J. Biol. Chem., Volume 276 (2001), pp. 11599-11605

[59] C. Darimont; G. Vassaux; D. Gaillard; G. Ailhaud; R. Négrel In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II, Int. J. Obes., Volume 18 (1994), pp. 783-788

[60] F. Massiéra; J. Seydoux; A. Geloen; A. Quignard-Boulangé; S. Turban; P. Saint-Marc; A. Fukamizu; R. Négrel; G. Ailhaud; M. Teboul Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity, Endocrinology, Volume 142 (2001), pp. 5220-5225

[61] L. Yvan-Charvet; P. Even; M. Block-Faure; M. Guerre-Millo; N. Moustaid-Moussa; P. Ferre; A. Quignard-Boulangé Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance, Diabetes, Volume 54 (2005), pp. 991-999

[62] K. Takahashi; S. Mizuarai; H. Araki; S. Mashiko; A. Ishihara; A. Kanatani; H. Itadani; H. Kotani Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice, J. Biol. Chem., Volume 278 (2003), pp. 46654-46660

[63] P. Sartipy; D.J. Loskutoff Monocyte chemoattractant protein-1 in obesity and insulin resistance, Proc. Natl Acad. Sci. USA, Volume 100 (2003), pp. 7265-7270

[64] J.A. Levine; M.D. Jensen; N.L. Eberhardt; T. O'Brien Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth, J. Clin. Invest., Volume 101 (1998), pp. 1557-1564

[65] A. Abderrahim-Ferkoune; O. Bezy; C. Chiellini; M. Maffei; P. Grimaldi; F. Bonino; N. Moustaid-Moussa; F. Pasqualini; A. Mantovani; G. Ailhaud; E.Z. Amri Characterization of the long pentraxin PTX3 as a TNFα induced, secreted protein of adipose cells, J. Lipid Res., Volume 44 (2003), pp. 994-1000

[66] C. Chiellini; A. Bertacca; S.E. Novelli; C.Z. Görgun; A.M. Ciccarone; A. Giordano; H. Xu; A. Soukas; M. Costa; D. Gandini; R. Dimitri; P. Bottone; P. Cecchetti; E. Pardini; L. Pereggo; R. Navalesi; F. Folli; L. Benzi; S. Cinti; J.M. Friedman; G.S. Hotamisligil; M. Maffei Obesity modulates the expression of haptoglobin in white adipose tissue via TNF-alfa, J. Cell. Physiol., Volume 190 (2002), pp. 251-258

Cité par

Takeshi Hashimoto; Katsuya Hirano Effects of mifepristone on adipocyte differentiation in mouse 3T3-L1 cells, Cellular Molecular Biology Letters, Volume 29 (2024) no. 1 | DOI:10.1186/s11658-024-00559-9
Ting Chu; Mao Sheng Yang A Review of Structural Features, Biological Functions and Biotransformation Studies in Adipose Tissues and an Assessment of Progress and Implications, Endocrine, Metabolic Immune Disorders - Drug Targets, Volume 23 (2023) no. 1, p. 12 | DOI:10.2174/1871530322666220827145241
Nikita A. Mitkin; Tatiana N. Unguryanu; Sofia Malyutina; Alexander V. Kudryavtsev Association between Alcohol Consumption and Body Composition in Russian Adults and Patients Treated for Alcohol-Related Disorders: The Know Your Heart Cross-Sectional Study, International Journal of Environmental Research and Public Health, Volume 20 (2023) no. 4, p. 2905 | DOI:10.3390/ijerph20042905
Tabassum Akter; Md. Monirul Islam; Khadiza Begum; Rahima Begum; Souraov Roy; Md. Abdur Rahman Ripon; Mohammad Tohidul Amin; Mohammad Salim Hossain Risperidone upregulates the expression of adhesion molecules VCAM-I, and P-selectin in high-fat diet-induced obese mice, Journal of Affective Disorders Reports, Volume 13 (2023), p. 100583 | DOI:10.1016/j.jadr.2023.100583
Alex Subias-Gusils; Adam Álvarez-Monell; Noemi Boqué; Antoni Caimari; Roger Mariné-Casadó; Rosa M. Escorihuela; Montserrat Solanas Effects of a Calorie-Restricted Cafeteria Diet and Oleuropein Supplementation on Adiposity and mRNA Expression of Energy Balance Related Genes in Obese Male Rats, Metabolites, Volume 13 (2023) no. 2, p. 147 | DOI:10.3390/metabo13020147
Albert Sufianov; Andrey Kostin; Sema Begliarzade; Valentin Kudriashov; Tatiana Ilyasova; Yanchao Liang; Albert Mukhamedzyanov; Ozal Beylerli Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications, Non-coding RNA Research, Volume 8 (2023) no. 2, p. 192 | DOI:10.1016/j.ncrna.2023.02.001
Faizullah Khan; Haroon Khan; Ajmal Khan; Masao Yamasaki; Naima Moustaid-Moussa; Ahmed Al-Harrasi; Shaikh Mizanoor Rahman Autophagy in adipogenesis: Molecular mechanisms and regulation by bioactive compounds, Biomedicine Pharmacotherapy, Volume 155 (2022), p. 113715 | DOI:10.1016/j.biopha.2022.113715
Maddalena Conte; Laura Petraglia; Paolo Poggio; Vincenza Valerio; Serena Cabaro; Pasquale Campana; Giuseppe Comentale; Emilio Attena; Vincenzo Russo; Emanuele Pilato; Pietro Formisano; Dario Leosco; Valentina Parisi Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue, Frontiers in Medicine, Volume 9 (2022) | DOI:10.3389/fmed.2022.844266
Waleed M. Altowayan; Abdulaziz M. Albidah; Abdulrhman I. Mohana; Khalid S. Alharbi A cross-sectional survey: The “Saudi guidelines for the prevention and management of obesity”: Awareness and adaptation in Al-Qassim province, Journal of Family Medicine and Primary Care, Volume 11 (2022) no. 10, p. 6291 | DOI:10.4103/jfmpc.jfmpc_631_22
Trevor D. Crafts; Jennifer E. Tonneson; Bruce M. Wolfe; Andrea M. Stroud Obesity and breast cancer: Preventive and therapeutic possibilities for bariatric surgery, Obesity, Volume 30 (2022) no. 3, p. 587 | DOI:10.1002/oby.23369
Andreas Goette; Uwe Lendeckel Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences, Cells, Volume 10 (2021) no. 10, p. 2605 | DOI:10.3390/cells10102605
Kelun Wu; Chuan He; Yue Wu; Xiaojie Zhou; Pan Liu; Wei Tang; Mei Yu; Weidong Tian Preservation of Small Extracellular Vesicle in Gelatin Methacryloyl Hydrogel Through Reduced Particles Aggregation for Therapeutic Applications, International Journal of Nanomedicine, Volume Volume 16 (2021), p. 7831 | DOI:10.2147/ijn.s334194
Mahdieh Sadat Mohsenzadeh; Bibi Marjan Razavi; Mohsen Imenshahidi; Seyed Abbas Tabatabaee Yazdi; Seyed Ahmad Mohajeri; Hossein Hosseinzadeh Potential role of green tea extract and epigallocatechin gallate in preventing bisphenol A-induced metabolic disorders in rats: Biochemical and molecular evidence, Phytomedicine, Volume 92 (2021), p. 153754 | DOI:10.1016/j.phymed.2021.153754
S. Esmaili; M. Hemmati; M. Karamian Physiological role of adiponectin in different tissues: a review, Archives of Physiology and Biochemistry, Volume 126 (2020) no. 1, p. 67 | DOI:10.1080/13813455.2018.1493606
Jitender Kumar; Brijesh Yadav; Arun Kumar Madan; Muneender Kumar; Rajneesh Sirohi; A. Vidyasagar Reddy Dynamics of heat-shock proteins, metabolic and endocrine responses during increasing temperature humidity index (THI) in lactating Hariana (Zebu) cattle, Biological Rhythm Research, Volume 51 (2020) no. 6, p. 934 | DOI:10.1080/09291016.2019.1566986
Ryan Kolb; Weizhou Zhang Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue, Cancers, Volume 12 (2020) no. 6, p. 1686 | DOI:10.3390/cancers12061686
Abdelnaby Khalyfa; Shobhan Gaddameedhi; Elena Crooks; Chunling Zhang; Yan Li; Zhuanhong Qiao; Wojciech Trzepizur; Steve A. Kay; Jorge Andrade; Brieann C. Satterfield; Devon A. Hansen; Leila Kheirandish-Gozal; Hans P. A. Van Dongen; David Gozal Circulating Exosomal miRNAs Signal Circadian Misalignment to Peripheral Metabolic Tissues, International Journal of Molecular Sciences, Volume 21 (2020) no. 17, p. 6396 | DOI:10.3390/ijms21176396
Jia Dong; Yue Wu; Yan Zhang; Mei Yu; Weidong Tian
Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair
, International Journal of Nanomedicine, Volume Volume 15 (2020), p. 6975 | DOI:10.2147/ijn.s269069
Bibi Marjan Razavi; Amir Reza Abazari; Maryam Rameshrad; Hossein Hosseinzadeh Carnosic acid prevented olanzapine-induced metabolic disorders through AMPK activation, Molecular Biology Reports, Volume 47 (2020) no. 10, p. 7583 | DOI:10.1007/s11033-020-05825-5
Flávia Giolo De Carvalho; Lauren M. Sparks Targeting White Adipose Tissue with Exercise or Bariatric Surgery as Therapeutic Strategies in Obesity, Biology, Volume 8 (2019) no. 1, p. 16 | DOI:10.3390/biology8010016
Hanyu Liang; Jia Nie; Candice E. Van Skike; Joseph M. Valentine; Miranda E. Orr Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes, Diabetes Mellitus, Volume 1128 (2019), p. 185 | DOI:10.1007/978-981-13-3540-2_10
Abdelnaby Khalyfa; David Sanz-Rubio Genetics and Extracellular Vesicles of Pediatrics Sleep Disordered Breathing and Epilepsy, International Journal of Molecular Sciences, Volume 20 (2019) no. 21, p. 5483 | DOI:10.3390/ijms20215483
Maryam Rameshrad; Bibi Marjan Razavi; Mohsen Imenshahidi; Hossein Hosseinzadeh Vitis vinifera (grape) seed extract and resveratrol alleviate bisphenol‐A‐induced metabolic syndrome: Biochemical and molecular evidences, Phytotherapy Research, Volume 33 (2019) no. 3, p. 832 | DOI:10.1002/ptr.6276
Jules Dichamp; Corinne Barreau; Christophe Guissard; Audrey Carrière; Yves Martinez; Xavier Descombes; Luc Pénicaud; Jacques Rouquette; Louis Casteilla; Franck Plouraboué; Anne Lorsignol 3D analysis of the whole subcutaneous adipose tissue reveals a complex spatial network of interconnected lobules with heterogeneous browning ability, Scientific Reports, Volume 9 (2019) no. 1 | DOI:10.1038/s41598-019-43130-9
CP Lee; CA Kushida; JA Abisheganaden Epidemiological and pathophysiological evidence supporting links between obstructive sleep apnoea and Type 2 diabetes mellitus, Singapore Medical Journal, Volume 60 (2019) no. 2, p. 54 | DOI:10.11622/smedj.2019015
Romina Abud; Maitte Salgueiro; Lauren Drake; Tomas Reyes; Jorge Jorquera; Gonzalo Labarca Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis, Sleep Medicine, Volume 62 (2019), p. 14 | DOI:10.1016/j.sleep.2018.12.017
MohamedR Halawa; AbeerA Abdullah; NesmaA Ibrahim; AhmedM El-Sabawy Chemerin is associated with diabetic retinopathy in type 2 diabetes, Egyptian Journal of Obesity, Diabetes and Endocrinology, Volume 4 (2018) no. 1, p. 23 | DOI:10.4103/ejode.ejode_26_17
Li Min; Shengguo Zhao; He Tian; Xu Zhou; Yangdong Zhang; Songli Li; Hongjian Yang; Nan Zheng; Jiaqi Wang Metabolic responses and “omics” technologies for elucidating the effects of heat stress in dairy cows, International Journal of Biometeorology, Volume 61 (2017) no. 6, p. 1149 | DOI:10.1007/s00484-016-1283-z
Shuhong Sun; Ran Wang; Jianwen Song; Ming Guan; Na Li; Xiaotian Zhang; Zhenwen Zhao; Junjie Zhang Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity, Journal of Lipid Research, Volume 58 (2017) no. 11, p. 2102 | DOI:10.1194/jlr.m075655
Yan Zhang; Mei Yu; Weidong Tian Physiological and pathological impact of exosomes of adipose tissue, Cell Proliferation, Volume 49 (2016) no. 1, p. 3 | DOI:10.1111/cpr.12233
Junhui Du; Rong Li; Lin Xu; Ranran Ma; Jiali Liu; Jing Cheng; Zhong Zhang; Hongzhi Sun Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients, Current Eye Research, Volume 41 (2016) no. 1, p. 114 | DOI:10.3109/02713683.2015.1004718
Ekaterina Vachkova; D. Bosnakovski; P. Yonkova; N. Grigorova; Zh. Ivanova; P. Todorov; G. Penchev; A. Milanova; G. Simeonova; S. Stanilova; I. Penchev Georgiev Adipogenic potential of stem cells derived from rabbit subcutaneous and visceral adipose tissue in vitro, In Vitro Cellular Developmental Biology - Animal, Volume 52 (2016) no. 8, p. 829 | DOI:10.1007/s11626-016-0048-7
Rui Liu; Na Li; Yi Lin; Mei Wang; Yongde Peng; Keidren Lewi; Qinghua Wang; Gregory M. Kelly Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin, PLOS ONE, Volume 11 (2016) no. 8, p. e0160212 | DOI:10.1371/journal.pone.0160212
Pascal Morissette Martin; Amandine Maux; Véronique Laterreur; Dominique Mayrand; Valérie L. Gagné; Véronique J. Moulin; Julie Fradette Enhancing repair of full-thickness excisional wounds in a murine model: Impact of tissue-engineered biological dressings featuring human differentiated adipocytes, Acta Biomaterialia, Volume 22 (2015), p. 39 | DOI:10.1016/j.actbio.2015.04.036
Fabio Maresca; Vito Di Palma; Michele Bevilacqua; Giuseppe Uccello; Vittorio Taglialatela; Alessandro Giaquinto; Giovanni Esposito; Bruno Trimarco; Plinio Cirillo Adipokines, Vascular Wall, and Cardiovascular Disease, Angiology, Volume 66 (2015) no. 1, p. 8 | DOI:10.1177/0003319713520463
Xin Wang; Chunxu Hai Redox modulation of adipocyte differentiation: hypothesis of “Redox Chain” and novel insights into intervention of adipogenesis and obesity, Free Radical Biology and Medicine, Volume 89 (2015), p. 99 | DOI:10.1016/j.freeradbiomed.2015.07.012
M. Nagafuku; T. Sato; S. Sato; K. Shimizu; T. Taira; J.-I. Inokuchi Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3, Glycobiology, Volume 25 (2015) no. 3, p. 303 | DOI:10.1093/glycob/cwu112
Yu Zhang; Yuling Zhu; Yaqin Li; Jiqing Cao; Huili Zhang; Menglong Chen; Liang Wang; Cheng Zhang Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice, Human Molecular Genetics, Volume 24 (2015) no. 21, p. 6029 | DOI:10.1093/hmg/ddv316
Gao Hong-Wei; Liu Lan; Xing De-Guo; Liu Zhong-Hao; Ren Peng; Li Zhi-Qiang; Shan Guo-Qiang; Gong Ming-Zhi NCoR negatively regulates adipogenic differentiation of mesenchymal stem cells, In Vitro Cellular Developmental Biology - Animal, Volume 51 (2015) no. 7, p. 749 | DOI:10.1007/s11626-015-9886-y
R.K. Chilukoti; A. Giese; W. Malenke; G. Homuth; A. Bukowska; A. Goette; S.B. Felix; J. Kanaan; H.-G. Wollert; K. Evert; S. Verheule; P. Jais; S.N. Hatem; U. Lendeckel; C. Wolke Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria, International Journal of Cardiology, Volume 187 (2015), p. 604 | DOI:10.1016/j.ijcard.2015.03.072
Elodie Luche; Coralie Sengenès; Emmanuelle Arnaud; Patrick Laharrague; Louis Casteilla; Beatrice Cousin Differential Hematopoietic Activity in White Adipose Tissue Depending on its Localization, Journal of Cellular Physiology, Volume 230 (2015) no. 12, p. 3076 | DOI:10.1002/jcp.25045
Li Min; Jian-bo Cheng; Bao-lu Shi; Hong-jian Yang; Nan Zheng; Jia-qi Wang Effects of heat stress on serum insulin, adipokines, AMP-activated protein kinase, and heat shock signal molecules in dairy cows, Journal of Zhejiang University-SCIENCE B, Volume 16 (2015) no. 6, p. 541 | DOI:10.1631/jzus.b1400341
Volkan Yumuk; Constantine Tsigos; Martin Fried; Karin Schindler; Luca Busetto; Dragan Micic; Hermann Toplak European Guidelines for Obesity Management in Adults, Obesity Facts, Volume 8 (2015) no. 6, p. 402 | DOI:10.1159/000442721
Nira Ben-Jonathan; Eric Hugo Prolactin (PRL) in Adipose Tissue: Regulation and Functions, Recent Advances in Prolactin Research, Volume 846 (2015), p. 1 | DOI:10.1007/978-3-319-12114-7_1
Cuiping Fu; Liyan Jiang; Fen Zhu; Zilong Liu; Wenjing Li; Hong Jiang; Hongying Ye; Clete A. Kushida; Shanqun Li Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats, Sleep and Breathing, Volume 19 (2015) no. 4, p. 1467 | DOI:10.1007/s11325-015-1144-8
Riccardo Schweizer; Wakako Tsuji; Vijay S. Gorantla; Kacey G. Marra; J. Peter Rubin; Jan A. Plock The Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis, Stem Cells International, Volume 2015 (2015), p. 1 | DOI:10.1155/2015/120949
Jie Li; Xiangchen Qiao; Mei Yu; Feng Li; Hang Wang; Weihua Guo; Weidong Tian Secretory Factors From Rat Adipose Tissue Explants Promote Adipogenesis and Angiogenesis, Artificial Organs, Volume 38 (2014) no. 2 | DOI:10.1111/aor.12162
S. Hatia; A. Septembre-Malaterre; F. Le Sage; A. Badiou-Bénéteau; P. Baret; B. Payet; C. Lefebvre d’hellencourt; M. P. Gonthier Evaluation of antioxidant properties of major dietary polyphenols and their protective effect on 3T3-L1 preadipocytes and red blood cells exposed to oxidative stress, Free Radical Research, Volume 48 (2014) no. 4, p. 387 | DOI:10.3109/10715762.2013.879985
Tsu-Shuen Tsao Assembly of adiponectin oligomers, Reviews in Endocrine and Metabolic Disorders, Volume 15 (2014) no. 2, p. 125 | DOI:10.1007/s11154-013-9256-6
Luisa N. Borrell; Elizabeth A. Nguyen; Lindsey A. Roth; Sam S. Oh; Haig Tcheurekdjian; Saunak Sen; Adam Davis; Harold J. Farber; Pedro C. Avila; Emerita Brigino-Buenaventura; Michael A. LeNoir; Fred Lurmann; Kelley Meade; Denise Serebrisky; William Rodriguez-Cintron; Rajesh Kumar; Jose R. Rodriguez-Santana; Shannon M. Thyne; Esteban G. Burchard Childhood Obesity and Asthma Control in the GALA II and SAGE II Studies, American Journal of Respiratory and Critical Care Medicine, Volume 187 (2013) no. 7, p. 697 | DOI:10.1164/rccm.201211-2116oc
Anjali Aggarwal; Ramesh Upadhyay Heat Stress and Hormones, Heat Stress and Animal Productivity (2013), p. 27 | DOI:10.1007/978-81-322-0879-2_2
M. Du; Y. Huang; A. K. Das; Q. Yang; M. S. Duarte; M. V. Dodson; M.-J. Zhu MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM: Manipulating mesenchymal progenitor cell differentiation to optimize performance and carcass value of beef cattle1,2, Journal of Animal Science, Volume 91 (2013) no. 3, p. 1419 | DOI:10.2527/jas.2012-5670
Raphael Gomes Fonseca; Vicencia Micheline Sales; Eduardo Ropelle; Carlos Castilho Barros; Lila Oyama; Silvia Saiuli Iuki Ihara; Mário Jose Abdalla Saad; Ronaldo Carvalho Araújo; João Bosco Pesquero Lack of kinin B1 receptor potentiates leptin action in the liver, Journal of Molecular Medicine, Volume 91 (2013) no. 7, p. 851 | DOI:10.1007/s00109-013-1004-6
Marcin Adamczak; Andrzej Wiecek The Adipose Tissue as an Endocrine Organ, Seminars in Nephrology, Volume 33 (2013) no. 1, p. 2 | DOI:10.1016/j.semnephrol.2012.12.008
Luca Vanella; Komal Sodhi; Dong Hyun Kim; Nitin Puri; Mani Maheshwari; Terry D Hinds; Lars Bellner; Dov Goldstein; Stephen J Peterson; Joseph I Shapiro; Nader G Abraham Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade, Stem Cell Research Therapy, Volume 4 (2013) no. 2 | DOI:10.1186/scrt176
Pascal Baret; Axelle Septembre-Malaterre; Michel Rigoulet; Christian Lefebvre d’Hellencourt; Muriel Priault; Marie-Paule Gonthier; Anne Devin Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from mitochondrial alterations induced by oxidative stress, The International Journal of Biochemistry Cell Biology, Volume 45 (2013) no. 1, p. 167 | DOI:10.1016/j.biocel.2012.10.007
Vanessa L. Williams; Rachel E. Martin; John L. Franklin; Robert W. Hardy; Joseph L. Messina Injury-induced insulin resistance in adipose tissue, Biochemical and Biophysical Research Communications, Volume 421 (2012) no. 3, p. 442 | DOI:10.1016/j.bbrc.2012.03.146
Patrizia Morera; Loredana Basiricò; Kenji Hosoda; Umberto Bernabucci Chronic heat stress up-regulates leptin and adiponectin secretion and expression and improves leptin, adiponectin and insulin sensitivity in mice, Journal of Molecular Endocrinology, Volume 48 (2012) no. 2, p. 129 | DOI:10.1530/jme-11-0054
Michael Pagliassotti Inter-Organ and -Tissue Communication via Secreted Proteins in Humans, Secretions and Exudates in Biological Systems, Volume 12 (2012), p. 269 | DOI:10.1007/978-3-642-23047-9_12
Claude A. Dechesne; Christian Dani Stem Cells from Human Adipose Tissue: A New Tool for Pharmacological Studies and for Clinical Applications, Adipose Stem Cells and Regenerative Medicine (2011), p. 121 | DOI:10.1007/978-3-642-20012-0_12
Fengna Li; Huansheng Yang; Yehui Duan; Yulong Yin Myostatin regulates preadipocyte differentiation and lipid metabolism of adipocyte via ERK1/2, Cell Biology International, Volume 35 (2011) no. 11, p. 1141 | DOI:10.1042/cbi20110112
Tusty-Jiuan Hsieh; Pei-Chen Hsieh; Ming-Tsang Wu; Wei-Chiao Chang; Pi-Jung Hsiao; Kun-Der Lin; Pong-Chun Chou; Shyi-Jang Shin Betel nut extract and arecoline block insulin signaling and lipid storage in 3T3-L1 adipocytes, Cell Biology and Toxicology, Volume 27 (2011) no. 6, p. 397 | DOI:10.1007/s10565-011-9195-5
K Clément Bariatric surgery, adipose tissue and gut microbiota, International Journal of Obesity, Volume 35 (2011) no. S3, p. S7 | DOI:10.1038/ijo.2011.141
Jiexiu Zhao; Ye Tian; Jincheng Xu; Dongsen Liu; Xiaofang Wang; Binxiu Zhao Endurance exercise is a leptin signaling mimetic in hypothalamus of Wistar rats, Lipids in Health and Disease, Volume 10 (2011) no. 1 | DOI:10.1186/1476-511x-10-225
I.M. Kruger; H.W. Huisman; A.E. Schutte The relationship between adiponectin, ageing and renal function in a bi-ethnic sample, Regulatory Peptides, Volume 169 (2011) no. 1-3, p. 58 | DOI:10.1016/j.regpep.2011.04.003
Mariana Cifuentes; Cecilia Fuentes; Pamela Mattar; Nicolas Tobar; Eric Hugo; Nira Ben-Jonathan; Cecilia Rojas; Jorge Martínez Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line, Archives of Biochemistry and Biophysics, Volume 500 (2010) no. 2, p. 151 | DOI:10.1016/j.abb.2010.05.033
Linglin Xie; M. Teresa Ortega; Silvia Mora; Stephen K. Chapes Interactive Changes between Macrophages and Adipocytes, Clinical and Vaccine Immunology, Volume 17 (2010) no. 4, p. 651 | DOI:10.1128/cvi.00494-09
Qinqiang Long; Ting Lei; Bin Feng; Changjun Yin; Dan Jin; Yanling Wu; Xiaoyue Zhu; Xiaodong Chen; Li Gan; Zaiqing Yang Peroxisome Proliferator-Activated Receptor-γ Increases Adiponectin Secretion via Transcriptional Repression of Endoplasmic Reticulum Chaperone Protein ERp44, Endocrinology, Volume 151 (2010) no. 7, p. 3195 | DOI:10.1210/en.2009-1501
Jin-Ah Yang; Hyung-Min Chung; Chong-Hyun Won; Jong-Hyuk Sung Potential application of adipose-derived stem cells and their secretory factors to skin: discussion from both clinical and industrial viewpoints, Expert Opinion on Biological Therapy, Volume 10 (2010) no. 4, p. 495 | DOI:10.1517/14712591003610598
Mariana Schroeder; Timothy H. Moran; Aron Weller Attenuation of obesity by early-life food restriction in genetically hyperphagic male OLETF rats: Peripheral mechanisms, Hormones and Behavior, Volume 57 (2010) no. 4-5, p. 455 | DOI:10.1016/j.yhbeh.2010.02.002
Mariana Schroeder; Vered Gelber; Timothy H. Moran; Aron Weller Long-term obesity levels in female OLETF rats following time-specific post-weaning food restriction, Hormones and Behavior, Volume 58 (2010) no. 5, p. 844 | DOI:10.1016/j.yhbeh.2010.08.008
Takashige Sato; Masaru Tanaka; Sadaaki Yamamoto; Emiko Ito; Kyoko Shimizu; Yasuyuki Igarashi; Masatsugu Shimomura; Jin-ichi Inokuchi Effect of Honeycomb-Patterned Surface Topography on the Function of Mesenteric Adipocytes, Journal of Biomaterials Science, Polymer Edition, Volume 21 (2010) no. 14, p. 1947 | DOI:10.1163/092050610x500615
Yu Wu; Shengli Zhou; Cynthia M. Smas Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion, Mechanisms of Development, Volume 127 (2010) no. 3-4, p. 183 | DOI:10.1016/j.mod.2009.12.003
Karine Clément Pathological Alteration of Human Adipose Tissue in Obesity, Novel Insights into Adipose Cell Functions (2010), p. 1 | DOI:10.1007/978-3-642-13517-0_1
Christian Dani Fat Cell Progenitors: Origins and Plasticity, Novel Insights into Adipose Cell Functions (2010), p. 77 | DOI:10.1007/978-3-642-13517-0_7
Sandrine Poglio; Fabienne De Toni-Costes; Emmanuelle Arnaud; Patrick Laharrague; Eric Espinosa; Louis Casteilla; Béatrice Cousin Adipose Tissue as a Dedicated Reservoir of Functional Mast Cell Progenitors, Stem Cells, Volume 28 (2010) no. 11, p. 2065 | DOI:10.1002/stem.523
Didier F. Pisani; Claude A. Dechesne; Sabrina Sacconi; Severine Delplace; Nathalie Belmonte; Olivia Cochet; Noémie Clement; Brigitte Wdziekonski; Albert P. Villageois; Catherine Butori; Claude Bagnis; James P. Di Santo; Jean-Yves Kurzenne; Claude Desnuelle; Christian Dani Isolation of a Highly Myogenic CD34-Negative Subset of Human Skeletal Muscle Cells Free of Adipogenic Potential, Stem Cells, Volume 28 (2010) no. 4, p. 753 | DOI:10.1002/stem.317
Benjamin D. Mackie; David G. Harrison; A. Maziar Zafari The Metabolic Syndrome, Advances in Vascular Medicine (2009), p. 423 | DOI:10.1007/978-1-84882-637-3_23
Siham Yasari; Donghao Wang; Denis Prud’homme; Marek Jankowski; Jolanta Gutkowska; Jean-Marc Lavoie Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -e in rats, Molecular and Cellular Biochemistry, Volume 324 (2009) no. 1-2, p. 13 | DOI:10.1007/s11010-008-9979-y
M Walter; S Liang; S Ghosh; P J Hornsby; R Li Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells, Oncogene, Volume 28 (2009) no. 30, p. 2745 | DOI:10.1038/onc.2009.130
Iris Östreicher; Udo Meißner; Christian Plank; Ida Allabauer; Hayo Castrop; Wolfgang Rascher; Jörg Dötsch Altered leptin secretion in hyperinsulinemic mice under hypoxic conditions, Regulatory Peptides, Volume 153 (2009) no. 1-3, p. 25 | DOI:10.1016/j.regpep.2008.11.011
Louis Casteilla; Luc Pénicaud; Béatrice Cousin; Denis Calise Choosing an Adipose Tissue Depot for Sampling, Adipose Tissue Protocols, Volume 456 (2008), p. 23 | DOI:10.1007/978-1-59745-245-8_2
Yu Wu; Cynthia M. Smas Wdnm1-like, a new adipokine with a role in MMP-2 activation, American Journal of Physiology-Endocrinology and Metabolism, Volume 295 (2008) no. 1, p. E205 | DOI:10.1152/ajpendo.90316.2008
Takashige Sato; Masakazu Nagafuku; Kyoko Shimizu; Toshio Taira; Yasuyuki Igarashi; Jin‐ichi Inokuchi Physiological levels of insulin and IGF‐1 synergistically enhance the differentiation of mesenteric adipocytes., Cell Biology International, Volume 32 (2008) no. 11, p. 1397 | DOI:10.1016/j.cellbi.2008.08.010
Xiu-ping BI; Hong-wei TAN; Shan-shan XING; Zhi-hao WANG; Meng-xiong TANG; Yun ZHANG; Wei ZHANG Overexpression of TRB3 Gene in Adipose Tissue of Rats with High Fructose-induced Metabolic Syndrome, Endocrine Journal, Volume 55 (2008) no. 4, p. 747 | DOI:10.1507/endocrj.k08e-049
Harold E Bays; J Michael González-Campoy; George A Bray; Abbas E Kitabchi; Donald A Bergman; Alan Bruce Schorr; Helena W Rodbard; Robert R Henry Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Review of Cardiovascular Therapy, Volume 6 (2008) no. 3, p. 343 | DOI:10.1586/14779072.6.3.343
Susumu OGAWA; Takefumi MORI; Kazuhiro NAKO; Sadayoshi ITO Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy, Hypertension Research, Volume 31 (2008) no. 6, p. 1147 | DOI:10.1291/hypres.31.1147
C Iliescu; L Béghin; L Maes; I De Bourdeaudhuij; C Libersa; C Vereecken; M Gonzalez-Gross; M Kersting; D Molnar; C Leclercq; M Sjöström; Y Manios; K Wildhalm; A Kafatos; L A Moreno; F Gottrand Socioeconomic questionnaire and clinical assessment in the HELENA Cross-Sectional Study: methodology, International Journal of Obesity, Volume 32 (2008) no. S5, p. S19 | DOI:10.1038/ijo.2008.178
Ping Wang; Edwin Mariman; Johan Renes; Jaap Keijer The secretory function of adipocytes in the physiology of white adipose tissue, Journal of Cellular Physiology, Volume 216 (2008) no. 1, p. 3 | DOI:10.1002/jcp.21386
Morichika Konishi; Hirotoshi Nakamura; Hiroyuki Miwa; Pierre Chambon; David M. Ornitz; Nobuyuki Itoh Role of Fgf receptor 2c in adipocyte hypertrophy in mesenteric white adipose tissue, Molecular and Cellular Endocrinology, Volume 287 (2008) no. 1-2, p. 13 | DOI:10.1016/j.mce.2008.02.010
Michael G. Dube; Rita Torto; Satya P. Kalra Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin-deficient diabetic obese mice, Peptides, Volume 29 (2008) no. 4, p. 593 | DOI:10.1016/j.peptides.2008.01.001
Zufang Huang; Shuangmu Zhuo; Jianxin Chen; Rong Chen; Xingshan Jiang Multiphoton microscopic imaging of adipose tissue based on second‐harmonic generation and two‐photon excited fluorescence, Scanning, Volume 30 (2008) no. 6, p. 452 | DOI:10.1002/sca.20130
MingZhou Li; Li Zhu; XueWei Li; SuRong Shuai; XiaoKun Teng; HuaSheng Xiao; Qiang Li; Lei Chen; YuJiao Guo; JinYong Wang Expression profiling analysis for genes related to meat quality and carcass traits during postnatal development of backfat in two pig breeds, Science in China Series C: Life Sciences, Volume 51 (2008) no. 8, p. 718 | DOI:10.1007/s11427-008-0090-0
Adam Goode; M. Satyanarayanan; Mei Chen; Anil Tarachandani; Lily Mummert; Rahul Sukthankar; Casey Helfrich; Alice Stefanni; Limor Fix; Jeffrey Saltzman, 2007 IEEE International Conference on Multimedia and Expo (2007), p. 695 | DOI:10.1109/icme.2007.4284745
Wendy Cousin; Coralie Fontaine; Christian Dani; Pascal Peraldi Hedgehog and adipogenesis: Fat and fiction, Biochimie, Volume 89 (2007) no. 12, p. 1447 | DOI:10.1016/j.biochi.2007.08.012
Silvia I Anghel; Walter Wahli Fat poetry: a kingdom for PPARγ, Cell Research, Volume 17 (2007) no. 6, p. 486 | DOI:10.1038/cr.2007.48
Rodolphe Anty; Philippe Gual; Pierre-Michel Huet; Yannick Le Marchand-Brustel; Albert Tran Les stéatopathies métaboliques : conséquences hépatiques du syndrome métabolique, Gastroentérologie Clinique et Biologique, Volume 31 (2007) no. 12, p. 1127 | DOI:10.1016/s0399-8320(07)78350-1
Xavier Pi-Sunyer The Metabolic Syndrome: How to Approach Differing Definitions, Medical Clinics of North America, Volume 91 (2007) no. 6, p. 1025 | DOI:10.1016/j.mcna.2007.06.004
Gabriel Perlemuter; Amélie Bigorgne; Anne-Marie Cassard-Doulcier; Sylvie Naveau Nonalcoholic fatty liver disease: from pathogenesis to patient care, Nature Clinical Practice Endocrinology Metabolism, Volume 3 (2007) no. 6, p. 458 | DOI:10.1038/ncpendmet0505
F. Xavier Pi-Sunyer The relation of adipose tissue to cardiometabolic risk, Clinical Cornerstone, Volume 8 (2006), p. S14 | DOI:10.1016/s1098-3597(06)80040-2

Cité par 100 documents. Sources : Crossref

Commentaires - Politique

Il n'y a aucun commentaire pour cet article. Soyez le premier à écrire un commentaire !

Publier un nouveau commentaire:

Publier une nouvelle réponse: